Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as ...

With the official confirmation that Cadillac F1 has earned approval to join the Formula 1 2026 grid comes new waves of ...

Mark Allen has asked fans to recommend a warm European country for a much-needed holiday after a “disappointing” defence of ...

Geron Corp's Rytelo launch & robust pipeline offer a compelling investment opportunity, despite stock challenges. Click here ...

Kryen Wilson has admitted he feels more confident than ever after beating defending champion Mark Allen at the Players ...

With these trends in view, let’s look at the 7 most undervalued biotech stocks to invest in.

US biotech Incyte (Nasdaq: INCY) has reported positive results from two Phase III trials of povorcitinib, an oral JAK1 inhibitor. The company said the trials, which tested the drug as an option for ...

A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic eczema achieved a “super-response,” by week 16, according to a presenter at the American Academy of ...

A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to severe atopic dermatitis, introducing a novel mechanism to treat ...

The round of eight Stage in the Player Championship competition will feature the match between Neil Robertson vs Stuart ...

Assassin's Creed Shadows reviews leak online, with one critic praising the title and going as far to say it's already 'iconic' in the AC franchise.